Blizard Jeffrey 4

What Happened
Jeffrey Blizard, a director of SANUWAVE Health, Inc. (SNVW), was granted a derivative award for 3,208 shares on 2026-03-31. The award is reported at a $0 acquisition price (typical for option or restricted awards) and, per the filing footnote, the options vested on the grant date. This is an award grant (not an open-market purchase or sale).

Key Details

• Transaction date: 2026-03-31; Form filed: 2026-04-02.
• Transaction type: Award/derivative grant (code A) for 3,208 shares at $0.00.
• Footnote: Options were vested at the grant date.
• Shares owned after the transaction: not specified in the provided filing.
• No sale or cash exercise reported; this was a grant, not a sale.
• Filing timeliness: filed on 2026-04-02; no late filing flag was provided in the summary materials.

Context
Derivative awards (options) that vest at grant provide the insider the right to acquire shares under specified terms; they are not the same as an immediate open-market purchase. Awards can be routine compensation for directors and do not by themselves indicate a buy/sell market signal. Retail investors should treat this as a compensation-related issuance unless further filings (e.g., exercises or sales) indicate otherwise.